Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
Integrating Acupuncture Into Postoperative Pain Management in Patients Undergoing Open Abdominal Operations
2 other identifiers
interventional
70
1 country
1
Brief Summary
This trial investigates how well acupuncture works for the management of pain after surgery in patients having open colorectal or pancreatic surgery. Acupuncture may help to reduce postoperative symptoms including pain. This study may help researchers learn if acupuncture reduces after-surgery side effects and improves recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2020
CompletedStudy Start
First participant enrolled
August 12, 2020
CompletedFirst Posted
Study publicly available on registry
September 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
December 23, 2025
December 1, 2025
7.4 years
July 27, 2020
December 19, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Adherence rate to daily acupuncture
Acupuncturist will document in the medical record all the treatments participants are completing and also document if missing any treatments.
Up to 7 days
Compliance
Acupuncturist and research coordinator will document in EPIC if participant is compliant with acupuncture sessions (study intervention) and with study questionnaires.
Up to 7 days
Retention
Will be measured as percentage of patients who complete the study out of the number of patients after study randomization.
Up to 7 days
Secondary Outcomes (3)
Postoperative opioid use for pain management
24 hours
Pain levels
Up to 7 days
Satisfaction of pain control
Up to 7 days
Other Outcomes (2)
Dietary recovery
Up to 7 days
Postoperative length of stay
Up to 7 days
Study Arms (2)
Arm I (acupuncture, usual care)
EXPERIMENTALBeginning the day after surgery, patients undergo acupuncture sessions over 25 minutes QD for up to 7 days. Patients also undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits.
Arm II (usual care)
ACTIVE COMPARATORPatients undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits.
Interventions
Undergo acupuncture
Undergo usual care
Ancillary studies
Eligibility Criteria
You may qualify if:
- Undergoing open gastrointestinal cancer resection (pancreatic or colorectal)
- Must understand and read English
- Sign a written informed consent and willing to follow protocol requirements
- Able to consent to treatment
You may not qualify if:
- Chronic opioid use \> 90 mg MME (morphine milligram equivalents) for more than 7 days
- Mechanical bowel obstruction
- Active seizure activity after admission
- Compromised cognitive function per referring physician and/or inability to cooperate with acupuncture procedure
- Direct admission to intensive care unit after operation will result in removal from protocol
- Prior intra-abdominal operation in the past 6 months
- Any contraindications to acupuncture including infections or inability to access acupoint sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lorenzo Cohen
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2020
First Posted
September 23, 2020
Study Start
August 12, 2020
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
December 23, 2025
Record last verified: 2025-12